Reduce MRSA Infection
Rates by Up to 96%1?
Take the first step with Nozin NOVASM Programs.
Get a Free Assessment
* These fields are required.
Take the first step with Nozin NOVASM Programs.
* These fields are required.
Nozin, leaders in developing and implementing MRSA / MSSA risk mitigation programs, introduces NOVASM. A proprietary suite of tools and services, NOVASM programs are guided by experienced consultants and proven to reduce infection risks while improving patient care.
Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) infections are a major component of total healthcare-associated infections (HAIs).
Patients who are colonized with MRSA in the nares are 14 to 20 times more likely to acquire MRSA infection than non-carriers.
NOVASM MRSA / MSSA colonization risk mitigation programs reduce colonization, which reduces infection risk.
Facilities that have adopted the NOVA programs approach are reporting significant outcomes such as:
| 96% |
reduction in MRSA bacteremia hospital-wide2 Advent Health North Pinellas, FL |
| 100% |
reduction in total hip and knee SSI2 Wellstar Cobb Hospital, GA |
| 74% |
decline in MRSA bacteremia2 Jackson Health System, FL |
Visit nozin.com/clinical-outcomes for more data.
Nozin NOVASM programs are a proprietary suite of analytical tools and services guided by experienced consultants. Built on shared knowledge from hundreds of facility implementations, NOVASM programs are proven to reduce infection risks while improving patient care.
We know that making the change from traditional strategies can be a challenge. Here’s what you can expect when you partner with Nozin NOVASM .
More outcomes data published or presented than for any other nasal antiseptic
15-year safety record
Millions of users
Fast, easy, pleasant application – preferred by staff and patients
Patented Nozaseptin® formula:
Proprietary Popswab® delivery system
More daily decolonization outcomes data
The right tool for MRSA / MSSA risk mitigation programs
Rechargeable for second nostril application
Facilities that have implemented Nozin NOVASM programs have shown up to $1.4 million annual cost savings2 and up to 60% reduction in PPE use2. Take the first step today.
Evidence counts. See why we’re the leader in daily nasal decolonization.
Download White Paper
Connie Steed, MSN, RN, CIC, FAPIC, has worked in the field of infection prevention and control for over 40 years. Connie’s experience encompasses academic and community acute care hospitals, Long -Term Care Facilities and Ambulatory care. Connie recently retired from her position as Corporate Director of Infection Control for Prisma Health. Connie is currently a consultant specializing in infection prevention and control. She is board certified in Infection Prevention and control (CIC) since 1985 and a Fellow of the Association for Professionals in Infection Control and Epidemiology (APIC). Connie has served APIC as a volunteer leader in multiple capacities including 2020 APIC President. She is published in the field and has presented nationally and internationally. Connie received her Bachelor’s and Master’s in Nursing from Clemson University.
Karen Hoffmann, RN, MS, BSN, CIC, FAPIC, FSHEA, has specialized in infection prevention and control for over 4 decades, serving for 23 years as the Associate Director of the North Carolina Statewide Program for Infection Control and Epidemiology (SPICE), and is an adjunct faculty at the University of North Carolina’s School of Medicine. Karen also served as the Infection Preventionist Consultant for the Centers for Medicare and Medicaid Services (CMS) from 2011 to 2020. She is a Fellow in both the Society of Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC). In 2019, Karen served as APIC President and has presented nationally and internationally. Karen earned her BS in Nursing from Indiana University and her Master’s in Healthcare Epidemiology from the University of Virginia.